Donor lymphocyte infusion followed by pentostatin, cyclophosphamide and rituximab therapy is effective for relapsed chronic lymphocytic leukemia after allogeneic stem cell transplant.
about
Donor lymphocyte infusion followed by pentostatin, cyclophosphamide and rituximab therapy is effective for relapsed chronic lymphocytic leukemia after allogeneic stem cell transplant.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Donor lymphocyte infusion foll ...... logeneic stem cell transplant.
@en
Donor lymphocyte infusion foll ...... logeneic stem cell transplant.
@nl
type
label
Donor lymphocyte infusion foll ...... logeneic stem cell transplant.
@en
Donor lymphocyte infusion foll ...... logeneic stem cell transplant.
@nl
prefLabel
Donor lymphocyte infusion foll ...... logeneic stem cell transplant.
@en
Donor lymphocyte infusion foll ...... logeneic stem cell transplant.
@nl
P2093
P2860
P1433
P1476
Donor lymphocyte infusion foll ...... logeneic stem cell transplant.
@en
P2093
Chishiho Nakamura
Hirokazu Hirata
Hitomi Kaneko
Mitsumasa Watanabe
Mitsuru Tsudo
Sumie Fujii
P2860
P304
P356
10.3109/10428194.2013.788698
P577
2013-04-30T00:00:00Z